This paper considers those sectors of the economy that operate under the same regimes of rewarding private innovators as others, but differ in that they face recurring problems of resistance, as occur in the pharmaceutical and agricultural industries. This recurrence originates in the natural...

This paper investigates the determinants of EPO (European Patent Office) patent applications per capita using a panel of 22 OECD countries with data measured as five-year averages for the period 1980-1999. The patent production function is specified as a partial adjustment model and is estimated...

In 2010 China was the world's fourth largest filer of patent applications. This followed a decade of unprecedented increases in investment in skills and Research and Development. If current trends continue China could rank first in the very near future. We provide evidence that the growth in...

Using firm level panel data from the U.S., I explore the relationship between firm size and R&D productivity for two important and R&D-intensive industries: Semiconductors and Pharmaceuticals. I employ two measures of a firm's R&D performance: the number of citations received per patented...

A key input to inventive activity is human capital. Hence it is important to understand the monetary incentives of inventors. We estimate the effect of patented inventions on individual earnings by linking data on U.S. patents and their inventors to Finnish employer-employee data. Returns are...

Die Wettbewerbsfähigkeit einer Volkswirtschaft hängt nicht zuletzt auch von der Innovationskraft ihrer wirtschaftlichen Akteure ab. Voraussetzung dafür sind Forschung und Entwicklung (FuE) in Unternehmen, Hochschulen und Forschungseinrichtungen und die Nutzung der regionalen...